photo walkheader_zpsd5bunpmi.png

Category Archives: Medical Research

“Modified” FOLFIRINOX Regimen Approved by FDA for 2nd Line Treatment of Pancreatic Cancer

On the 22nd of October, 2015, the U.S. Food and Drug Administration approved a new combination therapy that includes the drug Onivyde for patients with metastatic pancreatic cancer (ductal adenocarcinoma of the pancreas) who had earlier been treated until progression of disease while on gemcitabine or a gemcitabine-based regimen. Onivyde is liposomal irinotecan, a topoisomerase I […]

Pancreatic Cancer Work-up: Fine Needle Biopsy via EUS May Offer No Additional Risk

Although the true origin of the Latin phase “Primum non nocere” (First, do no harm) is a little murky, the principle can be traced to at least Hippocrates (or one of his students) written in Ionic Greek 2,500 years ago, and as recently as likely ALL first year training in contemporary medical schools. How might […]

Cell Surface Heparan Sulfate Proteoglycan for the Earlier Diagnosis of Pancreatic Cancer

Yesterday, European researchers and those from MD Anderson Cancer Center/ University of Texas in Houston published an article in the prestigious journal, Nature, which carries the possibility of being a game-changer in the earlier diagnosis and consequent treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas). It is difficult to overstate the potential for significant […]

Page 7 of 25« First...56789...20...Last »
Facebook
Facebook